Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
182 EUR | -2.39% | -7.09% | -23.99% |
May. 16 | Sartorius sinks again towards year low | DP |
May. 16 | Transcript : Sartorius Stedim Biotech S.A., Sartorius Aktiengesellschaft - Analyst/Investor Day |
Sales 2024 * | 2.94B 3.19B | Sales 2025 * | 3.33B 3.61B | Capitalization | 18.15B 19.7B |
---|---|---|---|---|---|
Net income 2024 * | 335M 364M | Net income 2025 * | 451M 490M | EV / Sales 2024 * | 6.95 x |
Net Debt 2024 * | 2.27B 2.46B | Net Debt 2025 * | 2.16B 2.34B | EV / Sales 2025 * | 6.1 x |
P/E ratio 2024 * |
52.5
x | P/E ratio 2025 * |
37.7
x | Employees | 10,493 |
Yield 2024 * |
0.4% | Yield 2025 * |
0.58% | Free-Float | 31.97% |
Latest transcript on Sartorius Stedim Biotech
1 day | -0.97% | ||
1 week | -5.74% | ||
Current month | -9.01% | ||
1 month | -11.92% | ||
3 months | -27.37% | ||
6 months | -10.99% | ||
Current year | -22.88% |
Managers | Title | Age | Since |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 19-03-25 |
Chairman | 59 | 07-06-28 | |
Chief Tech/Sci/R&D Officer | 59 | 09-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 07-06-28 |
Chairman | 59 | 07-06-28 | |
Susan Dexter
BRD | Director/Board Member | 67 | 15-04-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.42% | 17 M€ | +7.15% | - | |
0.35% | 5 M€ | +4.56% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-29 | 182 | -2.39% | 16 099 |
24-05-28 | 186.5 | -0.61% | 61,198 |
24-05-27 | 187.6 | -2.54% | 71,553 |
24-05-24 | 192.6 | +0.21% | 118,167 |
24-05-23 | 192.2 | -1.94% | 59,945 |
Real-time Euronext Paris, May 29, 2024 at 03:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.88% | 19.74B | |
-7.38% | 177B | |
-0.46% | 108B | |
-6.98% | 65.55B | |
+2.65% | 50.66B | |
+5.27% | 42.58B | |
+5.73% | 40.74B | |
+19.92% | 31.07B | |
+16.57% | 25.45B | |
-7.00% | 23.85B |
- Stock Market
- Equities
- DIM Stock